首页> 外国专利> Derivatives of N - (2-azabicyclo 2.1.1 HEX-1-IL) arylmethyl heterobenzamide, their production and their use in therapy

Derivatives of N - (2-azabicyclo 2.1.1 HEX-1-IL) arylmethyl heterobenzamide, their production and their use in therapy

机译:N-[(2-氮杂双环[2.1.1] HEX-1-IL)芳基甲基]杂苯甲酰胺的衍生物,其产生及其在治疗中的用途

摘要

1. The compound of general formula (I) in which — R represents a hydrogen atom or a group selected from (C — C) alkyl, (C — C) cycloalkyl, benzyl or allyl, optionally substituted with one or more groups selected independently of one another from halogen atoms, (C — C) cycloalkyl, (C — C) alkyl, (C — C) alkoxy, hydroxy; - R represents a phenyl or naphthyl group optionally substituted by one or more substituents selected independently from one another from halogen atoms, (C-C) alkyl, (C-C) alkoxy, halo (C-C) alkyl, hydroxy, halo (C-C) alkoxy, (C-C) alkylthio, (C-C ) alkyl-SO, (C-C) alkyl-SO; - Het is a heteroaryl group; - R is one or more substituents selected from a hydrogen atom, halogen atoms, halo (C-C) alkyl, (C-C) alkyl, (C-C) cycloalkyl, (C-C) cycloalkyl- (C-C) alkyl, (C-C) alkoxy, benzyl, (C-C) alkylthio, (C-C) alkyl-SO, (C-C ) alkyl-SO; in the form of a base or an addition salt with an acid. 2. A compound of general formula (I) according to claim 1, characterized in that R is a hydrogen atom, a benzyl group or an allyl group; R, Het and R are, however, as defined in claim 1, in the form of a base or an addition salt with an acid .3. A compound of general formula (I) according to claim 1, characterized in that R represents a phenyl or naphthyl group optionally substituted by one or more groups selected independently from one another from halogen atoms, (C-C) alkyl, (C-C) alkoxy , halo of (C — C) alkyl; R, Het and R are, as defined in claim 1, in the form of a base or an addition salt with an acid. 4. A compound of general formula (I) according to claim 1, characterized in that Het is indole, thiophene or pyridine; R, R and R are, however, as defined in claim 1, in the form of a base or a salt of
机译:1.通式(I)的化合物,其中-R代表氢原子或选自以下的基团:(C1-C4)烷基,(C1-C4)环烷基,苄基或烯丙基,任选地被一个或多个独立地选择的基团取代彼此独立地选自卤素原子,(CC)环烷基,(CC)烷基,(CC)烷氧基,羟基; -R代表任选地被一个或多个选自彼此独立的选自卤素原子,(CC)烷基,(CC)烷氧基,卤素(CC)烷基,羟基,卤素(CC)烷氧基,(CC)的取代基取代的苯基或萘基)烷硫基,(CC)烷基-SO,(CC)烷基-SO; -Het是杂芳基; -R是选自氢原子,卤素原子,卤代(CC)烷基,(CC)烷基,(CC)环烷基,(CC)环烷基的一个或多个取代基-(CC)烷基,(CC)烷氧基,苄基,( CC)烷硫基,(CC)烷基-SO,(CC)烷基-SO;以碱或与酸的加成盐的形式存在。 2.根据权利要求1的通式(I)的化合物,其特征在于R是氢原子,苄基或烯丙基;和然而,R,Het和R如权利要求1所定义,为碱或与酸的加成盐的形式3 .. 2.根据权利要求1所述的通式(I)的化合物,其特征在于,R表示任选地被一个或多个彼此独立地选自卤素原子,(CC)烷基,(CC)烷氧基,卤素的基团取代的苯基或萘基。 (CC)个烷基; R,Het和R如权利要求1所定义,为碱或与酸的加成盐的形式。 4.根据权利要求1的通式(I)的化合物,其特征在于Het是吲哚,噻吩或吡啶;和然而,R 1,R 2和R 3如权利要求1所定义,为碱或盐的形式。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号